Table 1 Comparison of characteristics between patients with and without a response from caregivers and results of test of homogeneity
Answered No (N = 174) | Answered Yes (N = 174) | Overall (N = 348) | p-value* | |
|---|---|---|---|---|
Age | 0.477 | |||
18–44 | 35 (20.1%) | 28 (16.1%) | 63 (18.1%) | |
45–59 | 35 (20.1%) | 43 (24.7%) | 78 (22.4%) | |
60–74 | 62 (35.6%) | 68 (39.1%) | 130 (37.4%) | |
75–93 | 42 (24.1%) | 35 (20.1%) | 77 (22.1%) | |
Sex | 0.914 | |||
Male | 79 (45.4%) | 81 (46.6%) | 160 (46.0%) | |
Female | 95 (54.6%) | 93 (53.4%) | 188 (54.0%) | |
Patient had partner | < 0.001 | |||
Yes | 77 (48.7%) | 120 (69.0%) | 197 (59.3%) | |
No | 81 (51.3%) | 54 (31.0%) | 135 (40.7%) | |
Type of cancer | 0.723 | |||
Hematological | 18 (11.1%) | 17 (9.8%) | 35 (10.4%) | |
Solid | 144 (88.9%) | 157 (90.2%) | 301 (89.6%) | |
Center of attention | 0.842 | |||
HUSI | 77 (44.3%) | 73 (42.0%) | 150 (43.1%) | |
HUSJ | 17 (9.8%) | 15 (8.6%) | 32 (9.2%) | |
INC | 80 (46.0%) | 86 (49.4%) | 166 (47.7%) | |
Health affiliation scheme | 0.319 | |||
Contributory | 103 (59.2%) | 104 (59.8%) | 207 (59.5%) | |
Special/exceptional | 3 (1.7%) | 0 (0.0%) | 3 (0.9%) | |
Private | 1 (0.6%) | 0 (0.0%) | 1 (0.3%) | |
Subsidized | 67 (38.5%) | 70 (40.2%) | 137 (39.4%) |